Beyond Medical Technologies Stock Performance
DOCKF Stock | USD 0.07 0.00 0.00% |
Beyond Medical holds a performance score of 9 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -335.1, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Beyond Medical are expected to decrease by larger amounts. On the other hand, during market turmoil, Beyond Medical is expected to outperform it. Use Beyond Medical standard deviation and the relationship between the jensen alpha and day typical price , to analyze future returns on Beyond Medical.
Risk-Adjusted Performance
OK
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Beyond Medical Technologies are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly conflicting forward-looking signals, Beyond Medical reported solid returns over the last few months and may actually be approaching a breakup point. ...more
Last Split Factor 1:10 | Dividend Date 2020-05-12 | Last Split Date 2022-12-30 |
1 | What to expect in US healthcare in 2025 and beyond - McKinsey | 01/10/2025 |
2 | 10 Years From Now, Youll Be Glad You Bought These Magnificent TSX Dividend Stocks - Yahoo Canada Finance | 01/29/2025 |
3 | Beyond Medical Welcomes AI Visionary Hongming Luo in Strategic Board Appointment - StockTitan | 02/04/2025 |
4 | Beyond Medical Technologies Inc. announced that it expects to receive CAD 0.375 million in funding - Marketscreener.com | 02/12/2025 |
5 | Beyond Medical Technologies Secures 375,000 in Private Placement and Appoints New COO - TipRanks | 02/24/2025 |
6 | Meet Max Kopp The 17-Year-Old Scientist Entrepreneur Redefining Innovation in Med-Tech Aerospace - Markets Insider | 03/19/2025 |
Begin Period Cash Flow | 536.8 K | |
Free Cash Flow | -527 K |
Beyond |
Beyond Medical Relative Risk vs. Return Landscape
If you would invest 2.00 in Beyond Medical Technologies on December 27, 2024 and sell it today you would earn a total of 5.00 from holding Beyond Medical Technologies or generate 250.0% return on investment over 90 days. Beyond Medical Technologies is currently producing 15.127% returns and takes up 127.9812% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than Beyond, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
Risk |
Beyond Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Beyond Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Beyond Medical Technologies, and traders can use it to determine the average amount a Beyond Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1182
Best Portfolio | Best Equity | DOCKF | ||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
127.98 actual daily | 96 96% of assets are less volatile |
Expected Return
4.96 actual daily | 96 96% of assets have lower returns |
Risk-Adjusted Return
0.12 actual daily | 9 91% of assets perform better |
Based on monthly moving average Beyond Medical is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Beyond Medical by adding it to a well-diversified portfolio.
Beyond Medical Fundamentals Growth
Beyond Stock prices reflect investors' perceptions of the future prospects and financial health of Beyond Medical, and Beyond Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Beyond Stock performance.
Return On Equity | -1.89 | ||||
Return On Asset | -3.8 | ||||
Current Valuation | 1.07 M | ||||
Shares Outstanding | 15.81 M | ||||
Price To Earning | 38.84 X | ||||
Price To Book | 17.94 X | ||||
Price To Sales | 1.41 X | ||||
Gross Profit | (250.49 K) | ||||
EBITDA | (773.19 K) | ||||
Net Income | (595.96 K) | ||||
Cash And Equivalents | 877.31 K | ||||
Cash Per Share | 0.01 X | ||||
Total Debt | 30 K | ||||
Debt To Equity | 0.04 % | ||||
Current Ratio | 3.73 X | ||||
Book Value Per Share | (0.07) X | ||||
Cash Flow From Operations | (527.04 K) | ||||
Earnings Per Share | (0.04) X | ||||
Market Capitalization | 1.11 M | ||||
Total Asset | 95.64 K | ||||
Retained Earnings | (26.1 M) | ||||
Working Capital | (334.72 K) | ||||
About Beyond Medical Performance
By analyzing Beyond Medical's fundamental ratios, stakeholders can gain valuable insights into Beyond Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Beyond Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Beyond Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Last Reported | Projected for Next Year | ||
Days Of Inventory On Hand | 113.37 | 107.70 | |
Return On Tangible Assets | (7.17) | (6.81) | |
Return On Capital Employed | 1.38 | 1.45 | |
Return On Assets | (7.17) | (6.81) | |
Return On Equity | 2.05 | 2.15 |
Things to note about Beyond Medical Techn performance evaluation
Checking the ongoing alerts about Beyond Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Beyond Medical Techn help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Beyond Medical Techn is way too risky over 90 days horizon | |
Beyond Medical Techn has some characteristics of a very speculative penny stock | |
Beyond Medical Techn appears to be risky and price may revert if volatility continues | |
Beyond Medical Techn has high likelihood to experience some financial distress in the next 2 years | |
Net Loss for the year was (595.96 K) with loss before overhead, payroll, taxes, and interest of (250.49 K). | |
Beyond Medical Technologies has accumulated about 877.31 K in cash with (527.04 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
Roughly 29.0% of the company shares are held by company insiders | |
Latest headline from news.google.com: Meet Max Kopp The 17-Year-Old Scientist Entrepreneur Redefining Innovation in Med-Tech Aerospace - Markets Insider |
- Analyzing Beyond Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Beyond Medical's stock is overvalued or undervalued compared to its peers.
- Examining Beyond Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Beyond Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Beyond Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Beyond Medical's stock. These opinions can provide insight into Beyond Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Beyond Stock analysis
When running Beyond Medical's price analysis, check to measure Beyond Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Beyond Medical is operating at the current time. Most of Beyond Medical's value examination focuses on studying past and present price action to predict the probability of Beyond Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Beyond Medical's price. Additionally, you may evaluate how the addition of Beyond Medical to your portfolios can decrease your overall portfolio volatility.
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |